A combination of 8-methoxypsoralen (8-MOP) and ultraviolet-A (UVA) radiation (320 ± 400 nm) (PUVA) is widely used in the treatment of psoriasis and other skin diseases. PUVA is highly effective in eliminating hyperproliferative cells in the epidermis, but its mechanism of action has not been fully elucidated. In this study, we used immortalized JB6 mouse epidermal cells, p53 7/7 , and Fas ligand deficient (gld) mice to investigate the molecular mechanism by which PUVA induces cell death. The results indicate that PUVA treatment induces apoptosis in JB6 cells. In addition, PUVA treatment of JB6 cells results in p53 stabilization, phosphorylation, and nuclear localization as well as induction of p21
Introduction
The human skin diseases, psoriasis, cutaneous T-cell lymphoma (CTCL), and vitiligo are commonly treated with a combination of psoralens and UVA radiation, commonly referred to as`PUVA' therapy.
1 ± 3 8-Methoxypsoralen (8-MOP) is a naturally occurring inert chemical that can be photoactivated by UVA to become a potent photosensitizing agent. It is a tricyclic aromatic compound with a planar structure that helps it intercalate between nucleic acid base pairs. UVA activates the intercalated complex, resulting in the formation of photoadducts with pyrimidines in cellular DNA. 4 ± 7 The psoralen monoadducts formed in the DNA can further react photochemically with a pyrimidine base on the complementary strand of the DNA, thus leading to crosslinks that are believed to be the primary cause of PUVA-induced cell killing. 7, 8 Even though PUVA treatment is known to be mutagenic and carcinogenic, 9 ± 13 it remains a treatment of choice for psoriasis and other skin disorders because its benefits far outweigh its risks.
Although many aspects of PUVA therapy have been studied extensively, the molecular mechanism by which it kills cells has not been fully elucidated. Some studies have shown that PUVA induces apoptosis in human lymphocytes and CTCL cell lines, 14 ± 20 but the precise pathways and molecules involved remain largely unidentified. In fact, except for one study with rat skin, in which induction of sunburn cells and DNA fragmentation were observed after PUVA treatment, in vitro or in vivo studies have not been performed to evaluate the mechanisms of cell death in epidermal cells, which are the primary targets of treatment for psoriasis. 21 Many studies have shown that the p53 protein is influential in mediating apoptosis. The p53 phosphoprotein acts as the guardian of the genome by halting the cell cycle to allow repair or, if repair is not possible, promoting cell death by apoptosis. 22, 23 DNA-damaging agents such as UV and ionizing radiation induce high levels of p53, 24 ± 27 which in turn activate the transcription of downstream genes responsible for cell-cycle arrest at the G 1 -S transition. 28 In particular, p53 can activate p21
Waf1/Cip1 , which binds to and inactivates the cyclin-dependent kinases required for cellcycle progression 29 and may activate genes involved in DNA repair while the cell cycle is arrested. 30 Alternatively, if the damage is irreparable, p53 may activate genes involved in apoptosis. 31 Most DNA-damaging agents induce apoptosis via a p53-mediated pathway, although apoptosis may be induced in a p53-independent manner as well. 32 ± 34 Studies with p53 7/7 mice have shown that p53 is required for the elimination of DNA-damaged skin cells through apoptosis. 35 UV irradiation induces the expression of both Fas (APO-1/CD95) and its ligand (FasL) in keratinocytes at mRNA and protein levels. 36 Although previous studies have reported that PUVA treatment induces p53 expression in epidermal cells 37 and in the skin of individuals with psoriasis, 38 it is unknown whether p53 and Fas/FasL interactions are in fact required for PUVA-induced apoptosis. In this study, we used in vitro and in vivo approaches using JB6 mouse epidermal cells and p53 7/7 and fasL 7/7 (gld) mice to answer these questions.
Results

PUVA treatment decreases viability of JB6 cells
After several preliminary dose-response experiments using the MTT viability assay, 10 mg/ml 8-MOP and 20 kJ/m 2 UVA were selected for further studies because this combination caused cell death in a time-dependent manner, whereas treatment with 8-MOP or UVA alone did not. To quantify PUVA-induced cell death in JB6 epidermal cells, viable cell density was determined using the trypan blue dye exclusion assay. As shown in Figure 1 , PUVA treatment caused apparent growth arrest at 24 h, followed by cell death at 48 and 72 h. The number of ethanol-treated cells increased by 180, 235, and 320% at 24, 48, and 72 h after treatment, respectively, while the number of PUVA-treated cells decreased to 90, 30, and 18% of viable cells at time 0. These results indicate that the population of cells in the control group approximately doubled every 24 h. However, the population of cells in the PUVA-treated group remained approximately the same at 24 h, and decreased greatly at 48 and 72 h after treatment, suggesting initial growth arrest followed by cell death. JB6 cells treated with 8-MOP or UVA alone did not undergo cell death and the percentage of viable cells at 0 ± 72 h after treatment was comparable to cells treated with ethanol at 0 ± 72 h time points, respectively (data not shown).
PUVA treatment induces apoptosis in JB6 cells
Apoptotis results in characteristic morphological changes, including nuclear condensation, cytoplasmic vesiculation, and the formation of membrane-bound bodies that can be phagocytosed by other cells. 39 These changes can be observed by fluorescence microscopy or transmission electron microscopy (TEM). 40 TEM analysis of PUVA-treated cells revealed morphological characteristics of apoptosis such as cytoplasmic vesiculation, condensation, and margination of the nuclear chromatin 24 h after treatment ( Figure 2A ) and had formed apoptotic bodies 48 to 72 h after treatment (data not shown).
In addition to exhibiting specific morphological changes, cells that die by apoptosis undergo a variety of characteristic biochemical changes. 41 A hallmark of apoptosis is the formation of 180-to 200-bp segments that are a result of double-stranded DNA fragmentation at the linker regions between nucleosomes. As shown in Figure 2B , PUVA treatment resulted in the appearance of ladders at 48 and 72 h after treatment, indicating that the DNA was fragmented. No evidence of ladder formation was seen in cells treated with 8-MOP or UVA at any time point (data not shown).
We also performed terminal deoxyribonucleotidyl transferase (TdT)-mediated dUTP nick end labeling (TUNEL) to quantify apoptotic JB6 cells at different times after PUVA. The results of three independent experiments are shown in Figure 3A . Fluorescence activated cell sorting (FACS) analysis revealed an average of 9, 22, and 60% TUNELpositive cells in the PUVA-treated cells at 24, 48, and 72 h, respectively. There were fewer than 5% apoptotic cells in the groups treated with ethanol, 8-MOP, or UVA alone. The differences between ethanol and PUVA-treated cells were statistically significant at 48 and 72 h after PUVA with Pvalues of 50.01 (two-tailed t-test). To confirm the FACS data, we used fluorescence microscopy to visualize DNA strand breaks. PUVA-treatment resulted in the detection of TUNEL-positive cells; ethanol-treated cells however, did not appear to be TUNEL-positive (data not shown). Thus, the qualitative and quantitative data obtained from these experiments indicated that apoptosis does occur in JB6 mouse epidermal cells treated with PUVA and that DNA fragmentation is a relatively late event.
PUVA treatment induces caspase-3 activity in JB6 cells A significant amount of data supports a role for caspase-3 in apoptosis following exposure to a variety of DNA-damaging agents. 42 Caspases are involved in the proteolysis of cytoskeletal and other proteins involved in cellular integrity and cell adhesion. Cleavage of such proteins helps the dying cell to detach and round up, making it easier to be disposed of. We measured caspase-3 activity to determine whether caspases are involved in PUVA-induced apoptosis. As shown in Figure 3B , caspase-3 activity was significantly increased in PUVA-treated cells at 48 and 72 h after PUVA treatment. This observation is temporally consistent with the appearance of DNA fragmentation detected by the ladder assay and FACS analysis. There was no change in caspase-3 activity in 8-MOP or UVA alone treated cells (data not shown).
Induction/stabilization of p53 in PUVA-treated JB6 cells
Because PUVA treatment induces DNA damage, which is known to result in activation and/or stabilization of p53, we analyzed PUVA-treated JB6 cells for p53 expression at various times after treatment. A representative Western blot shown in Figure 4A reveals that PUVA treatment caused increased expression of p53 by 6 h, which reached peak levels by 24 to 48 h. In contrast, p53 levels were undetectable in JB6 cells treated with ethanol, 8-MOP, or UVA alone (data not shown). Note that the two distinct bands, p50 and p40, that migrated below 53 kD consistently appeared after PUVA treatment and may be cleavage products resulting from in vivo or in vitro protease activation; several investigators have reported the generation of similar p53-cleavage products in cell-free systems. 43 ± 45 Alternatively, the bands may be the result of nonspecific binding of the p53 antibody to an unknown neoantigen.
To assess whether the p53 protein was phosphorylated, we performed Western blot analyses with lysates of ethanol-and PUVA-treated cells and antibodies specific for phosphorylated sites on p53. As shown in Figure 4B , p53 was phosphorylated at serine 15 (aminoterminus) and serine 389 (carboxyterminus) in PUVA-treated cells at 24 h. Interestingly, the two bands corresponding to cleavage products (p50 and p40) of p53 were also phosphorylated at serine 389 but these two bands were absent in the blot probed with p53 serine 15-specific antibody. These results suggest that p50 and p40 cleavage products are missing portions of p53 at the Nterminus. Nonetheless, the phosphorylation data provide evidence that p53 may be functionally activated by PUVA treatment. In contrast, exposure to ethanol ( Figure 4B) , UVA, or 8-MOP (data not shown) did not result in the phosphorylation of p53.
Induction of p21
Waf1/Cip1 in PUVA-treated JB6 cells
There is a great deal of evidence indicating that after DNA damage, p53 can transcriptionally activate p21 Waf1/Cip1 , a cyclin-dependent kinase inhibitor. 29, 46 Furthermore, p21
Waf1/Cip1 forms a quaternary complex with cyclins and cyclin-dependent kinases that prevents them from phosphorylating targets required for cellular proliferation. In addition, p21
Waf1/Cip1 can also directly affect DNA replication through its interaction with proliferating cell nuclear antigen. 46 In PUVA-treated JB6 cells, the levels of p21
Waf1/Cip1 increased at 6 to 12 h, decreased at 24 h, and were undetectable at 48 h after treatment ( Figure 4A ), indicating that p21
Waf1/Cip1 may be involved in regulating cell-cycle arrest in PUVA-treated cells. Induction of p21
Waf1/Cip1 appeared to be a relatively early event, occurring between 6 and 12 h after treatment, perhaps to cause cell-cycle arrest to allow for DNA repair.
We also analyzed PUVA-treated JB6 cells for expression of Bcl-2 and Bax, two candidate p53 targets that play wellestablished roles in apoptosis. 47 However, we did not detect changes in Bcl-2 or Bax levels at any time point examined (data not shown). This was not surprising, as the role of these proteins in preventing or promoting apoptosis may depend upon their subcellular localization or whether they form dimers and not necessarily upon changes in the levels of their expression. 48 
PUVA treatment causes nuclear translocalization of p53 in JB6 cells
The Western blot data provided evidence for increased expression or stabilization of p53. As a surrogate marker to determine whether p53 was functionally activated after PUVA treatment, we analyzed p53 localization to the nucleus by immunofluorescence staining and confocal microscopy using a fluorescein isothiocyanate (FITC)-conjugated antibody to detect p53 and propidium iodide (PI) to detect the nucleus. Figure 5 shows that the p53 protein was translocated to the nucleus at 6 h after treatment in PUVA-treated cells but not in ethanol-treated control cells. These data suggest that p53 is activated as early as 6 h after PUVA treatment, most likely to function as a transcription factor for proteins involved in cell-cycle arrest, DNA repair, and/or apoptosis.
PUVA treatment induces Fas expression in JB6 cells
Because wild-type p53 is known to transcriptionally activate Fas, which is known to play a key role in apoptosis, we investigated whether PUVA treatment induces Fas expression in JB6 cells. The results shown in Figure 6 PUVA treatment fails to induce apoptosis in p53 7/ 7 and gld mice As discussed before, most DNA-damaging agents induce apoptosis via a p53-mediated pathway, although apoptosis may be induced in a p53-independent manner as well. 32 ± 34 To determine whether PUVA-induced apoptosis requires functional p53 and Fas/FasL interaction, we treated p53
and gld (fasL 7/7 ) mice, along with wild-type (p53 +/+ and fasL +/+ ) mice with PUVA and analyzed their skin for the presence of TUNEL-positive cells at various times posttreatment. Representative data shown in Figure 7 reveal the presence of numerous TUNEL-positive cells in the epidermis of PUVA-treated wild-type mice at 72 h post-treatment. In contrast, very few TUNEL-positive cells were present in the epidermis of PUVA treated p53 7/7 and gld mice at 72 h post treatment. Quantitative data shown in Figure 8 reveal that wild-type mice had 22 ± 36% TUNEL-positive cells compared to 8 ± 15% in p53 7/7 mice and only 2% in the gld mice at 24 ± 72 h, respectively. These data represent statistically significant differences with P values of 50.01 and 50.001 (twotailed t-test) and provide compelling evidence that both p53 and FasL are required for the apoptotic response in mice exposed to PUVA. As expected, TUNEL-positive cells were absent in 8-MOP or UVA alone treated mice regardless of genotype (data not shown).
PUVA treatment causes increased expression of Fas and FasL in p53
+/+ mouse skin
Previous studies have shown that Fas/FasL interaction is required for UV-induced apoptosis. 49, 50 To determine whether p53-dependent apoptosis in PUVA-treated mice involves Fas and FasL interactions, PUVA-treated skin from p53 +/+ and p53 7/7 mice were analyzed for Fas and FasL expression by immunohistochemical staining. The results shown in Figure 9 indicate that both wild-type and p53 7/7 mice treated with PUVA expressed more Fas ( Figure 9A ) and FasL ( Figure 9B ) in the epidermis compared to ethanol-treated control mice. However, there appeared to be more Fas and FasL expression in the epidermis of PUVA treated p53 +/+ mice than in the epidermis of p53 7/7 mice at 48 h post treatment, suggesting that p53 may be required to transcriptionally activate Fas, which in turn affects FasL levels. Immunohistochemical analysis also revealed that the p53 levels increased in p53 +/+ and gld mice at 24 to 72 h after PUVA and the protein was phosphorylated at serine 15 (data not shown), indicating functional activation of p53. Again, 8-MOP or UVA alone did not cause increased expression of Fas and FasL in wild-type, p53 +/+ or p53 7/7 mouse skin (data not shown).
Discussion
In this study, we have demonstrated that treatment of mouse epidermal cells with PUVA results in cell death by apoptosis in vitro and in vivo. That cell death resulted from the synergistic action of PUVA is clear because, at the doses used, neither 8-MOP nor UVA alone were cytotoxic to JB6 cells or to epidermal cells in wild-type, p53 7/7 , and gld mice. We used several criteria to demonstrate that PUVA-induced cell death in mouse epidermal cells involves apoptosis. First, TEM studies revealed that PUVA-treated cells exhibit many of the characteristic morphological features of apoptosis, including nuclear condensation, cytoplasmic vesiculation, and the formation of apoptotic bodies. Second, PUVA treatment of JB6 cells produced a faint pattern of DNA ladders at 48 and 72 h. Third, TUNEL analysis provided quantitative data demonstrating that PUVA-treated cells underwent DNA fragmentation. More importantly, PUVA treatment also caused cell death by apoptosis in vivo, as detected by the TUNEL assay. The time course for the apoptotic response in vivo was similar to that in vitro, as the cells underwent apoptosis 48 ± 72 h after PUVA treatment in both cases. Apoptosis, from the initial cell shrinkage to the removal of apoptotic bodies, requires up to 72 h in epidermal cells, 51 which is consistent with what we observed. Our finding that PUVA induces apoptosis in mouse epidermal cells is in agreement with other reports. One study reported that PUVA induces apoptosis in the squamous cell carcinoma cell line A431 as shown by annexin V binding and PI uptake. 52 In addition, a case report of the use of PUVA therapy to achieve remission in a patient with adult T cell leukemia indicated that the leukemic cells died by apoptosis based on TEM findings. 53 Another report showed that PUVA treatment induced sunburn cells and DNA fragmentation in rat skin. 21 However, none of these studies investigated the underlying mechanisms in PUVA-induced apoptosis.
Several studies have shown that agents that damage DNA induce high levels of p53 24, 25, 27 and accumulation of p53 in Figure 5 Confocal laser scanning microscopy of PUVA-treated JB6 cells showing translocation of p53 from the cytoplasm to the nucleus. The cells were stained with pan-p53 antibody followed by a FITC-conjugated secondary antibody (green color) (left panels). DNA was stained with PI to identify the nucleus (red color) (middle panels). The overlays show p53 staining superimposed on PI staining (yellow color) (right panels) (6006) the nucleus. 54, 55 Our data also demonstrate that PUVA treatment of JB6 mouse epidermal cells results in both stabilization of p53 and its translocation to the nucleus as early as 6 h after PUVA treatment. In addition, we found that p53 was phosphorylated at serine 15 on the N terminus and at serine 389 on the C terminus, providing further evidence for p53 activation. Although some studies have shown that PUVA treatment induces p53 in the reconstituted human-skin equivalent EpiDerm 37 and in the skin of psoriasis patients 38 these studies did not address the question of whether PUVA induces apoptosis. Here, we demonstrate that PUVA induces apoptosis in mouse epidermal cells in vitro and in vivo and involves the p53 pathway. In addition to UVB (280 ± 320 nm), UVA radiation is known to induce p53 in MCF-7 cells, human epidermal cells, and keratinocytes.
56 ± 59 However, we did not detect p53 induction in JB6 cells treated with UVA alone. Perhaps this discrepancy could be due to the fact that the dose (20 kJ/ m 2 ) of UVA used in our studies was very low compared to those in other studies (150 ± 200 kJ/m 2 ). 56 ± 59 Moreover, because irradiation of JB6 cells with 20 kJ/m 2 UVA alone did not cause cell death, the UVA dose we used may not be high enough to inflict DNA damage and induce p53.
In addition to induction and translocation of the p53 protein from the cytoplasm to the nucleus, PUVA treatment also induced p21
Waf1/Cip1 expression. PUVA induction of p21 Waf1/Cip1 closely followed p53 induction and translocation, which suggests that p21
Waf1/Cip1 was transcriptionally activated by p53. However, p21
Waf1/Cip1 expression began to decrease 24 h after PUVA treatment and was undetectable 48 h after treatment, perhaps because p21 Waf1/Cip1 was rapidly degraded. DNA-damaging agents, including UV, ionizing radiation, and a variety of chemical and biological agents, have been reported to activate p21
Waf1/Cip1 in a p53-dependent manner. 29, 60 Many of the proteins associated with apoptosis are also involved in the control of proliferation, providing further evidence for the important link between cell-cycle progression and apoptosis. Therefore, we can hypothesize that in PUVA-treated cells, p21
Waf1/Cip1 causes cell-cycle arrest and then the cells begin to undergo apoptosis, perhaps as a result of their inability to repair damaged DNA. During this time, caspases may cleave key regulatory and structural proteins that are necessary for maintaining the integrity of the plasma membrane, cytoskeleton, and nucleus. 42 This hypothesis is supported by our finding that PUVA treatment caused a significant increase in caspase-3 activity in PUVA-treated JB6 cells at 48 to 72 h after treatment.
Given that other DNA-damaging agents induce high levels of p53 24 ± 27,61 and p53 has been reported to be involved in the induction of apoptosis, 22, 23, 62 it is reasonable to hypothesize that p53 is also required for PUVAinduced apoptosis. One study reported the involvement of p53 in the induction of apoptosis in tumor-promotorsensitive (P+) and promotion-insensitive (P7) JB6 cells following treatment with phenethyl isothiocyanate (PEITC), a chemoprotective agent. 63 The authors reported that PEITC inhibited tumor promoter-induced cell transformation and induced apoptosis in the JB6 C141 cell line. The same concentrations of PEITC caused p53 transactivation in a dose-and time-dependent manner, which led the investigators to conclude that p53 was associated with the apoptotic response. This observation was supported by the fact that PEITC induced apoptosis in p53 +/+ but not in p53 7/7 cells. More importantly, our in vivo data in p53
mice provide compelling evidence that p53 is required for the apoptotic response in PUVA-treated mouse epidermal cells. There was a statistically significant difference between the numbers of apoptotic cells in the p53 +/+ and p53 7/7 mice at 24, 48, and 72 h. However, there were 8 ± 15% apoptotic cells in the p53 7/7 mice after treatment, indicating that other mechanisms may be involved in the response to PUVA treatment. Similarly, it is reported that UVB radiation also induces some apoptosis in the epidermis of p53 7/7 mice, but only about one-fourth that observed in p53 +/+ mice. 35, 64 This may be because other apoptotic pathways such as Fas/FasL get activated, even in the absence of p53 after PUVA treatment.
Recent in vivo studies have shown that Fas/FasL interaction is required for the elimination of UV-damaged sunburn cells and that loss of FasL contributes to the development of UV-induced skin cancer. 49, 50 Binding of FasL to Fas activates an apoptotic cascade in a variety of cell types exposed to diverse stimuli. The interaction of Fas/FasL plays a critical role in the depletion of peripheral T lymphocytes 65 and the maintenance of immunological privilege by eliminating inflammatory cells. 66 Following activation by FasL, the intercellular death domain of Fas oligomerizes and recruits the adaptor protein called Fasassociated death domain (FADD). 67 ± 69 The death effector domain of FADD recruits the initiator procaspase-8 to the 70 or through a transcription-independent mechanism involving its translocation from the golgi to the cell's surface. 71 The levels of surface Fas expression increased significantly in PUVA-treated JB6 cells 48 ± 72 h after treatment. Because Fas is a transcriptional target of p53, it is likely that after PUVA treatment, p53 induces Fas expression, which in turn activates caspase-3, ultimately resulting in apoptosis. This conclusion is supported by the finding that PUVA treatment induced Fas expression as well as caspase-3 activity in JB6 cells 48 ± 72 h after PUVA.
The apparently higher levels of Fas and FasL expression in p53 +/+ mice than in p53 7/7 mice after PUVA treatment further suggests that p53 may mediate apoptosis by transcriptionally regulating Fas expression. Our finding that TUNEL-positive cells were totally absent in PUVA treated gld mice indicates that Fas/FasL interactions are absolutely required for PUVA-induced apoptosis. Fas is constitutively expressed on a variety of lymphoid and nonlymphoid cells, including the skin. 72, 73 In addition, studies with gld mice have demonstrated an essential role for FasL in UVBinduced apoptosis. 50 The similarity between UVB induced apoptosis and PUVA-induced apoptosis seen in p53 7/7 and gld mice is quite interesting because UVB and PUVA do not cause the same type of DNA damage. While UVB induces primarily cyclobutyl pyrimidine dimers and pyrimidine(6-4)pyrimidone photoproducts, 74 PUVA induces monofunctional adducts and DNA cross-links. 4 ± 7 These observations suggest that even though UVB and PUVA induce different types of DNA damage, the pathways leading to apoptosis may be similar or even the same. In summary, our data indicate that PUVA induces apoptosis in mouse epidermal cells in vitro and in vivo, and that p53 and Fas/FasL interactions are essential for this process, at least in vivo. These findings imply that similar mechanisms may be involved in the elimination of hyperproliferative psoriatic keratinocytes from the human skin following PUVA therapy.
Materials and Methods
PUVA treatment of JB6 cells
JB6, an immortalized, nontumorigenic epidermal cell line, established from BALB/c mouse skin, 75 was acquired from the American Type Figure 9 Immunohistochemical analysis of Fas (A) and FasL (B) in p53 +/+ and p53 7/7 mice 48 h after PUVA treatment. A secondary Cyanine-5-conjugated antibody, which appears red, was used to identify the proteins. The nuclei were counterstained with the green dye Sytox. Original magnification, 2006 Culture Collection (Manassas, VA, USA). The cells were routinely plated in 10-cm dishes with Dulbecco's modified Eagle's Medium (Gibco BRL, Grand Island, NY, USA) containing 10% bovine calf serum (Gibco BRL) at 378C in a 10% CO 2 atmosphere. Eighteen hours later, the medium was removed, and the cells were washed once with phosphate-buffered saline (PBS). 8-MOP (Sigma Chemical Co., St. Louis, MO, USA), diluted in 100% ethanol, was added to PBS for a final concentration of 10 mg/ml. 8-MOP was added to the cells, and they were incubated for 10 min at 378C in a humidified 5% CO 2 incubator. They were then irradiated with 20 kJ/m 2 UVA from two Mylar-filtered Sylvania F15T8/BLB lamps (320 ± 400 nm, peak 365 nm; Danvers, MA, USA) without their lids; the Mylar removed all wavelengths shorter than 320 nm. The irradiance of the Mylar-filtered F15T8/BLB lamps was 32 W/m 2 , as measured by a spectroradiometer (IL 700A; International Light, Inc., Newburyport, MA, USA). After irradiation, the cells were washed once with PBS and incubated at 378C. Control cells were mock-treated with PBS containing 1% ethanol, 8-MOP, or UVA irradiation alone. The entire operation was performed with the overhead room lights and tissue-culture hood fluorescent lights off.
Mice
Seven-week old C57BL/6 wild-type, p53 7/7 , and gld mice were purchased from the Jackson Laboratories (Bar Harbor, MA, USA). We did not use lpr (Fas 7/7 ) mice because it is a leaky mutation and the mice can express some Fas. Such expression may affect how epidermal cells respond to PUVA in vivo and could cause confounding results. The animals were permitted to adapt to our animal facility for 1 week in a room with alternating 12-h light and dark cycles and controlled temperature and humidity. Water and food were provided ad libitum. All animal procedures and facilities were reviewed and approved by the University of Texas M.D. Anderson Cancer Center Institutional Animal Care and Use Committee.
PUVA treatment of mice
Wild-type C57BL/6, p53 7/7 , and gld mice were divided into four groups of six animals each. Their backs were shaved with electric clippers. Each group of mice received either topical application of vehicle (100% ethanol), 8-MOP (100 mg per 4 cm 2 ), UVA (50 kJ/m 2 ), or both 8-MOP and UVA (PUVA). The animals were placed in standard cages covered with Mylar under six UVA lamps that emitted 4.5 W/m 2 , as measured by a spectroradiometer. Each cage held five mice placed in individual compartments separated with Plexiglas dividers. The animals were placed aside for 30 min to allow the 8-MOP to penetrate the skin. The cages containing the UVA and PUVA-treated mice were then placed on a shelf below the UVA lamps for the duration of the exposure. At 24, 48, and 72 h after PUVA treatment, two mice from each group were randomly selected and killed, and their skins processed for analysis. Dorsal skin (approximately 161 cm) was excised from the treated area and immediately fixed in 4% buffered formaldehyde for paraffin-embedded sectioning. The paraffin-embedded skin was cut into 5 mm sections for hematoxylin and eosin staining, TUNEL, and immunofluorescence analysis.
JB6 cell viability
A method developed by Mosmann was used to select an appropriate dose of 8-MOP and UVA for use in PUVA treatment. 76 Cells were plated at a density of 10 4 cells/well in 96-well microtiter plates for 24 h and treated with 1% ethanol vehicle or various concentrations of 8-MOP and/or UVA. At specified times after treatment, 20 ml of 3-(4-5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT, 1 mg/ml in PBS; Sigma Chemical Co.) was added to the wells containing 200 ml of medium. After a 4-h incubation at 378C, the medium/MTT mixture was replaced with 100 ml of DMSO (Sigma Chemical Co.). OD 570 was measured after 30 min with a 96-well microtiter plate spectrophotometer (Cerus UV900C; Lionheart Technologies, Inc., Carson City, NV, USA). Cell survival was calculated as a percentage of the OD of control (ethanol treated) cells in order to select an appropriate dose of PUVA.
The trypan blue dye exclusion assay was used to determine the number of viable cells just prior to PUVA treatment and at 24, 48, and 72 h after PUVA treatment. Cells were plated at a density of 2610 6 cells/plate in 10 cm plates for 24 h and then treated with 1% ethanol vehicle, 8-MOP, UVA, or PUVA, as described. Dishes from each treatment group were randomly selected, trypsinized and an aliquot of cells was counted in a suspension of 0.1% trypan blue dye. Only viable cells were counted to determine percent cell survival after treatment, which was calculated as a percentage of the cells that were counted at time 0 for each respective group.
DNA ladder formation
The ladder assay is based on the oligonucleosomal DNA fragmentation of nuclear DNA that can be visualized by ethidium bromide staining following electrophoresis as previously described.
77 JB6 cells were plated in 10-cm dishes (2610 6 cells/dish) and treated with PUVA, 8-MOP, UVA, or 1% ethanol vehicle. At 24, 48, and 72 h, cells were trypsinized and combined with floating cells in the same culture. DNA was isolated by lysing the cells in 500 ml of 0.2% Triton-X, 20 mM EDTA, and 1 mM Tris, pH 8.0, for 20 min on ice. The DNA fragments were harvested by centrifugation for 15 min at 14 0006g. After the addition of 600 ml of isopropanol and 100 ml of 5 M NaCl, the DNA in the supernatant was precipitated for 24 h at 7208C, centrifuged at 14 0006g for 10 min, dried, and incubated for 1 h at 658C in TE buffer containing 0.2 mg/ml proteinase K and 1 mg/ml RNAse A. The DNA fragments were resolved by electrophoresis at 100 V on 1.5% agarose gels impregnated with ethidium bromide, detected by UV transillumination, and photographed.
Terminal deoxyribonucleotidyl transferase mediated dUTP nick-end labeling (TUNEL) assay in JB6 cells
After PUVA treatment, adherent cells were trypsinized and combined with nonadherent cells of the same culture. DNA nick end labeling was performed with the fluorescein apoptosis detection system kit (Promega Biotech, Madison, WI, USA). Control and treated cells were fixed, permeabilized, and incubated with terminal deoxyribonucleotidyl transferase that catalyzes the addition of FITC-labeled deoxyuridine triphosphates to the 3' ends of double-and singlestranded DNA. The cells were counterstained with propidium iodide (PI) to identify the nuclei of the cells for sorting. The flow cytometer detected fluorescence at 623 nm for PI and at 520 nm for fluorescein. The cells were analyzed by FACS and the percentages of apoptotic cells were determined with EPICS Elite Software. Ten thousand cells were evaluated for each sample, and the data are taken from one experiment representative of the three performed.
TUNEL assay in mouse skin
The paraffin embedded 5-mm tissue sections were deparaffinized, hydrated, dehydrated, and analyzed for apoptotic cells using the fluorescein apoptosis detection system kit from Promega Biotech. The sections were stained with PI, and apoptotic cells were detected with a Zeiss fluorescent microscope (Carl Zeiss, Inc., Thornwood, NY, USA) using a Hamamatsu C5810 chilled camera (Hamamatsu, Bridgewater, NJ, USA). A composite figure was prepared using Adobe Photoshop software (Adobe Systems, Inc., San Jose, CA, USA). TUNEL-negative and TUNEL-positive cells in a 2006 field were counted with Optimas software (Media Cybernetics, Silver Spring, MD, USA). TUNEL sections were prepared from two mice in every treatment group at all time points, and four fields in each tissue section were examined. The number of TUNEL-positive cells was divided by the total number of cells to determine the percentage of apoptotic cells. The mean values and standard errors were calculated with Excel TM software (Microsoft, Redmond, WA, USA). A two-tailed t-test was performed and P values were calculated to determine significance. P values less than 0.05 were taken as significant.
Caspase-3 assay
The activity of caspase-3 was measured in ethanol-, 8-MOP, UVA-and PUVA-treated cells using a method developed by Gurtu et al. 78 Cells were harvested by trypsinization and centrifuged at 30006g for 10 min at 24 to 72 h. The cell pellets were resuspended in lysis buffer (100 mM HEPES, 10% sucrose, 1 mM EDTA, and a protease inhibitor cocktail (Mini-Tablet TM ; Boehringer Mannheim, Indianapolis, IN, USA) on ice. After 20 min, the samples were centrifuged at 14 0006g for 10 min. The supernatant was assayed for caspase-3 activity using 50 nM Ac-DEVD-AFC (Enzyme Systems Products, Livermore, CA, USA), a synthetic fluorogenic substrate consisting of an acetyl group attached to a peptide containing aspartic acid, glutamic acid, valine, and aspartic acid (DEVD). (Caspases can proteolytically cleave between the D and AFC, thereby releasing the fluorogenic molecule, which can be detected by spectrofluorometry). The samples were placed in a 378C water bath for 15 min and transferred to cuvettes containing 1 ml of lysis buffer. Fluorescence resulting from the release of AFC from DEVD was measured with a RF-1501 spectrofluorometer (Shimadzu Corp., Tokyo, Japan) using an excitation wavelength of 400 nm and an emission wavelength of 505 nm. Data represent means+SE of triplicate determinations. A two-tailed t-test was performed, and P values were calculated to determine significance. P values less than 0.05 were deemed significant.
Western blot analysis
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS ± PAGE) was performed to measure protein expression in JB6 cells after PUVA using a method described by Laemmli. 79 Three to 72 h after the cells were treated with 1% ethanol, 8-MOP, UVA, or PUVA, the medium was removed and the monolayer rinsed with cold PBS. The cells were scraped off the plates, added to the medium, and centrifuged at 30006g for 5 min. The pellet was rinsed in 1 ml of PBS, centrifuged at 30006g, and resuspended in lysis buffer (120 mM NaCl, 25 mM Tris, pH 7.5, and 1% Triton X) containing a protease inhibitor cocktail (Mini-Tablet TM ; Roche Diagnostics, Indianapolis, IN, USA). After the cells were lysed for 20 min on ice, the lysates were centrifuged at 14 0006g for 10 min. The protein concentrations were determined by the Bradford assay, 80 and 20 to 100 mg of protein was electrophoresed in 8 ± 12% SDS polyacrylamide gels at approximately 100 V for 2 h, depending on the protein of interest. The separated proteins were transferred to 2-mm nitrocellulose membranes (Protran; Intermountain Scientific Corp., Kaysville, UT, USA) and blocked with 3% milk in 250 mM Tris-buffered saline, pH 7.4, with 0.5% Tween. The blots were probed with antibodies against p53 (Ab-240; Transduction Laboratories, Lexington, KY, USA), phosphorylated p53 (Ab-ser15 and Ab-ser392; New England Biolabs, Beverly, MA, USA), p21
Waf1/Cip1 (Ab-4; Oncogene Research Products, Cambridge, MA, USA), Bcl-2 (PharMingen, San Diego, CA, USA), and Bax (Santa Cruz Biotechnology, Santa Cruz, CA, USA). To ensure the loading of equal amounts of protein, the blots were probed with anti-actin antibody (Amersham Corp., Arlington Heights, IL, USA). After incubation with the appropriate secondary antibody, signals were detected with chemiluminescent reagents (Pierce, Rockford, IL, USA) and autoradiography.
Immunocytochemical analysis and confocal microscopy
Treated and control cells grown on poly-L-lysine-coated slides (Sigma Chemical Co) were fixed in 4% paraformaldehyde, permeabilized with 0.3% Triton X-100, and blocked in 5% normal horse serum and 1% normal goat serum. After 1 h, the cells were incubated with 1 : 100 anti-p53 antibody (pan-p53; Boehringer Mannheim) overnight at 48C, washed three times with PBS, and incubated overnight with a FITC-conjugated sheep immunoglobulin G antibody (Boehringer Mannheim) in blocking buffer. The cells were washed in PBS and stained with propidium iodide. The slides were examined with a Zeiss confocal laser scanning microscope with an argon laser (488 nm, 10 mw), and signals were obtained with a 590-nm PI long-pass filter and a 520 ± 560 nm (FITC) bandpass filter. Digitized images were transmitted to a Macintosh-based image analysis system by using BDS-LSM software (Biological Detection Systems, Pittsburgh, PA, USA). A composite image was prepared with Adobe Photoshop software. 
Surface Fas expression on JB6 cells
Immunohistochemical analysis of mouse tissue sections
Briefly, 5-mm tissue sections were deparaffinized and treated with target retrieval solution (DAKO, Carpinteria, CA, USA). The sections were washed three times with PBS and blocked with 5% normal horse serum and 1% normal goat serum in PBS for 20 min. The slides were incubated overnight at 48C with antibodies specific for p53 (CM5; NovaCastra), Fas (M-20), FasL (N-20), or p21
Waf1/Cip1 (Santa Cruz Biotechnology) diluted 1 : 100 in serum. After three washes with PBS, the sections were incubated at room temperature for 2 h with anti-rabbit immunoglobulin G cyanineconjugated antibody (Jackson Immunoresearch Laboratories, Bar Harbor, MA, USA) diluted 1 : 200 in serum. The slides were washed three times, and the nuclei were stained with 10 mg/ml Sytox (Molecular Probes, Eugene, OR, USA) in PBS for 2 min and washed three times with PBS. Excess PBS was removed, Prolong anti-fade reagent (Molecular Probes) was added, and a coverslip was placed on each slide. The cells were examined with a Zeiss fluorescence microscope. A composite image was prepared with Adobe Photoshop TM software.
